Peptidyl-tRNA Hydrolase (Pth) is a highly conserved, essential enzyme in bacteria. It removes the peptide portion from peptidyl-tRNA, returning free tRNAs to participate in translation. Build-up of peptidyl-tRNAs is toxic and defects in Pth function result in cell death. Herein we use in vitro activity of recombinant E. coli Pth to screen tropical plant extracts for inhibition. Multiple extracts were found to have inhibitory activity with some exhibiting different inhibitory effects depending on extraction conditions. IC50 values ranged from 0.02 to > 53.8 μg of extract per 1 unit of Pth, holding promise for in vivo screening. The inhibitory components in these extracts may serve as lead compounds for development of novel antibacterials.
Brotz-OesterheltH., SassP. (2010) Postgenomic strategies in antibacterial drug discovery. Future Microbiology, 5, 1553–1579.
2.
CassellG.H., MekalanosJ. (2001) Development of antimicrobial agents in the era of new and reemerging infectious diseases and increasing antibiotic resistance. The Journal of the American Medical Association, 285, 601–605.
SamuelssonG., BohlinL. (2001) Drugs of Natural Origin, 6th Edition, Swedish Pharmaceutical Press, Stockholm, Sweden, 1–551.
5.
HarrisS.M., McFeetersH., OgungbeI.V., Cruz-VeraL.R., SetzerW.N., JackesB.R., McFeetersR.L. (2011) Peptidyl-tRNA hydrolase screening combined with molecular docking reveals the antibiotic potential of Syzygium johnsonii bark extract. Natural Product Communications, 6, 1421–1424.
6.
DasG., VarshneyU. (2006) Peptidyl-tRNA hydrolase and its critical role in protein biosynthesis. Microbiology, 152, 2191–2195.
7.
PulavartiS.V., JainA., PathakP.P., MahmoodA., AroraA. (2008) Solution structure and dynamics of peptidyl-tRNA hydrolase from Mycobacterium tuberculosis H37Rv. Journal of Molecular Biology, 378, 165–177.
8.
Rosas-SandovalG., AmbrogellyA., RinehartJ., WeiD., Cruz-VeraL.R., GrahamD.E., StetterK.O., GuarnerosG., SollD. (2002) Orthologs of a novel archaeal and of the bacterial peptidyl-tRNA hydrolase are nonessential in yeast. Proceedings of the National Academy of Science, 99, 16707–16712.
9.
SetzerM.C., SetzerW.N., JackesB.R., GentryG.A., MoriarityD.M. (2001) The medicinal value of tropical rainforest plants from Paluma, north Queensland, Australia. Pharmaceutical Biology, 39, 67–78.
10.
SetzerM.C., WerkaJ.S., IrvineA.K., JackesB.R., SetzerW.N. (2006) Biological activity of rainforest plant extracts from far north Queensland, Australia. Biologically Active Natural Products for the 21st century, WilliamsL.A.D. (Ed.), Research Signpost, Trivandrum, India.
11.
SetzerM.C., MoriarityD.M., LawtonR.O., SetzerW.N., GentryG.A., HaberW.A. (2003) Phytomedicinal potential of tropical cloudforest plants from Monteverde, Costa Rica. Revista de Biologia Tropical, 51, 647–674.
12.
SchmidtJ.M., NolettoJ.A., VoglerB., SetzerW.N. (2006) Abaco bush medicine. Journal of Herbs, Spices, and Medicinal Plants, 12, 43–65.
13.
Cruz-VeraL.R., ToledoI., Hernandez-SanchezJ., GuarnerosG. (2000) Molecular basis for the temperature sensitivity of Escherichia coli pth (Ts). Journal of Bacteriology, 182, 1523–1528.
14.
VarshneyU., LeeC.P., SeongB.L., RajBhandaryU.L. (1991) Direct analysis of aminoacylation levels of tRNAs in vivo. Application to studying recognition of Escherichia coli initiator tRNA mutants by glutaminyl-tRNA synthetase. Journal of Biological Chemistry, 266, 24712–24718.
